NASDAQ:OFIX

Orthofix Medical - OFIX Stock Forecast, Price & News

$23.03

+0.51 (+2.26%)

(As of 08/11/2022 12:00 AM ET)

Add

Compare

Today's Range: $22.63
▼
$23.09
50-Day Range: $21.98
▼
$27.47
52-Week Range: $21.66
▼
$43.30

Volume: 59,860 shs
Average Volume: 99,251 shs
Market Capitalization: $458.57 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $45.00

Orthofix Medical MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 95.4% Upside
$45.00 Price Target
Short Interest: Bearish
2.22% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.52
Based on 10 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 2.22%
From $0.45 to $0.46 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.93 out of 5 stars

Medical Sector

813th out of 1,112 stocks

Surgical & Medical Instruments Industry

79th out of 113 stocks

3.5

Analyst's Opinion

Consensus Rating
Orthofix Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $45.00, Orthofix Medical has a forecasted upside of 95.4% from its current price of $23.03.
Amount of Analyst Coverage
Orthofix Medical has received no research coverage in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
2.22% of the float of Orthofix Medical has been sold short.
Short Interest Ratio / Days to Cover
Orthofix Medical has a short interest ratio ("days to cover") of 4.
Change versus previous month
Short interest in Orthofix Medical has recently increased by 5.87%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Orthofix Medical does not currently pay a dividend.
Dividend Growth
Orthofix Medical does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for OFIX.

2.0

News and Social Media Coverage

News Sentiment
Orthofix Medical has a news sentiment score of 0.52. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 10 news articles for Orthofix Medical this week, compared to 1 article on an average week.
Search Interest
Only 2 people have searched for OFIX on MarketBeat in the last 30 days. This is a decrease of -60% compared to the previous 30 days.
MarketBeat Follows
Only 1 people have added Orthofix Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Orthofix Medical insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 3.50% of the stock of Orthofix Medical is held by insiders.
Percentage Held by Institutions
97.93% of the stock of Orthofix Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Orthofix Medical are expected to grow by 2.22% in the coming year, from $0.45 to $0.46 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Orthofix Medical is -12.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Orthofix Medical is -12.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Orthofix Medical has a P/B Ratio of 1.34. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Orthofix Medical (NASDAQ:OFIX) Stock

Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures. This segment also designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and a portfolio of products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions, as well as markets regenerative non-tissue biologic solutions derived from synthetic materials. The Global Orthopedics segment designs, develops, and markets orthopedic products that are used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

Wall Street Analyst Weigh In

Separately, StockNews.com raised Orthofix Medical from a "hold" rating to a "buy" rating in a research report on Monday.

Orthofix Medical Price Performance

Shares of NASDAQ:OFIX opened at $22.52 on Thursday. The business has a fifty day moving average of $24.83 and a two-hundred day moving average of $28.98. Orthofix Medical has a 52-week low of $21.66 and a 52-week high of $43.30. The company has a debt-to-equity ratio of 0.06, a current ratio of 3.15 and a quick ratio of 1.95.

Receive OFIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Orthofix Medical and its competitors with MarketBeat's FREE daily newsletter.

OFIX Stock News Headlines

August 11, 2022 | americanbankingnews.com

Orthofix Medical (NASDAQ:OFIX) Upgraded to "Buy" at StockNews.com

August 10, 2022 | seekingalpha.com

Orthofix Medical Inc. 2022 Q2 - Results - Earnings Call Presentation

August 5, 2022 | finance.yahoo.com

Orthofix Reports Second Quarter 2022 Results

August 5, 2022 | finance.yahoo.com

Orthofix (OFIX) Beats Q2 Earnings and Revenue Estimates

August 4, 2022 | apnews.com

CGBio Signing a North America Out-license Contract on “Novosis rhBMP-2,” a Bone Substitute with Orthofix, USA

August 2, 2022 | finance.yahoo.com

Orthofix Medical and CGBio Announce Strategic Partnership Agreement for Novosis rhBMP-2 Bone Graft Solutions

July 29, 2022 | finance.yahoo.com

Foot And Ankle Devices Global Market Report 2022

July 28, 2022 | marketwatch.com

Bone Growth Stimulator Market Type, Regional Outlook, Future Scope, and Leading Players, Trends, Demand Growth Revenue Analysis Report to 2028

July 27, 2022 | finance.yahoo.com

Orthofix Medical Schedules Second Quarter Earnings Release and Conference Call for August 5, 2022

July 26, 2022 | finance.yahoo.com

Orthofix Announces First Clinical Use of Virtuos Lyograft – a First-of-Its-Kind, Shelf-Stable and Complete Autograft Substitute for Spine and Orthopedic Procedures

July 25, 2022 | nz.finance.yahoo.com

Artificial Cervical Intervertebral Disc Market Size Worth $4.37 Bn Globally, by 2028 at 18.0% CAGR - Exclusive Report by The Insight Partners

July 19, 2022 | apnews.com

Conventus Flower Orthopedics Appoints Bradley Niemann as Chief Executive Officer

July 18, 2022 | finance.yahoo.com

Investors in Orthofix Medical (NASDAQ:OFIX) have unfortunately lost 52% over the last three years

July 13, 2022 | finance.yahoo.com

Orthofix Medical and LimaCorporate Announce Partnership to Provide Solution for Patients with High Hip Dislocation for the US Market

June 19, 2022 | finance.yahoo.com

Is Now An Opportune Moment To Examine Orthofix Medical Inc. (NASDAQ:OFIX)?

June 16, 2022 | marketwatch.com

Spine Biologics Market Share, Size 2022 | Business Revenue, Future Growth, Trends, Top Key Players, Business Opportunities | Forecast to 2028

June 14, 2022 | marketwatch.com

Global Bracing and Support (B&S) Market Advancement and Future Scope Till 2027

June 6, 2022 | nz.finance.yahoo.com

Worldwide Trauma Implants Industry to 2031 - Featuring Conformis, Orthofix Medical and Acumed Among Others

June 1, 2022 | msn.com

Looking Into Orthofix Medical's Return On Invested Capital

May 31, 2022 | finance.yahoo.com

Orthofix M6-C Artificial Cervical Disc IDE Study Data to be Presented at ISASS Demonstrates Continued Statistically Significant Benefits at Five Years

May 31, 2022 | finance.yahoo.com

A number of insiders bought Orthofix Medical Inc. (NASDAQ:OFIX) stock last year, which is great news for shareholders

May 18, 2022 | tmcnet.com

Catalyst OrthoScience Announces Todd Wilson, PhD as Vice President of Medical Education and Training

May 6, 2022 | finance.yahoo.com

Orthofix (OFIX) Reports Q1 Loss, Tops Revenue Estimates

May 6, 2022 | finance.yahoo.com

Orthofix Reports First Quarter 2022 Results

May 4, 2022 | marketwatch.com

Orthofix Receives FDA Premarket Approval for Bone-Healing Device

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive OFIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Orthofix Medical and its competitors with MarketBeat's FREE daily newsletter.

OFIX Company Calendar

Last Earnings: 11/05/2021
Today: 8/12/2022
Next Earnings (Estimated): 11/04/2022
Fiscal Year End: 12/31/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Surgical & medical instruments
Sub-Industry: Health Care Equipment
Sector: Medical
Current Symbol: NASDAQ:OFIX
CUSIP: N6748L10
CIK: 884624
Web: www.orthofix.com
Phone: (214) 937-2000
Fax: 599 9 461 6978
Employees: 1,087
Year Founded: 1980

Price Target and Rating

Average Stock Price Forecast: $45.00
High Stock Price Forecast: $45.00
Low Stock Price Forecast: $45.00
Forecasted Upside/Downside: +95.4%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.86)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 51.18
P/E Growth: N/A
Net Income: $-38,380,000.00
Net Margins: -8.00%
Pretax Margin: -2.92%
Return on Equity: 1.90%
Return on Assets: 1.38%

Debt

Debt-to-Equity Ratio: 0.06
Current Ratio: 3.15
Quick Ratio: 1.95

Sales & Book Value

Annual Sales: $464.48 million
Price / Sales: 0.99
Cash Flow: $3.28 per share
Price / Cash Flow: 7.03
Book Value: $17.17 per share
Price / Book: 1.34

Miscellaneous

Outstanding Shares: 19,912,000
Free Float: 19,215,000
Market Cap: $458.57 million
Optionable: Optionable
Beta: 1.01

Social Links

Key Executives

Mr. Jon C. Serbousek (Age 61)
Pres, CEO & Director
Comp: $1.61M
Mr. Douglas C. Rice (Age 56)
CFO & Chief Accounting Officer
Comp: $782.49k
Ms. Kimberley A. Elting (Age 57)
Chief Legal & Devel. Officer and Pres of the Global Orthopedics
Comp: $781.15k
Mr. Kevin J. Kenny (Age 57)
Pres of Global Spine Bus.
Comp: $778.96k
Mr. Roberto Donadello
Sr. VP of Global Operations
Dr. James T. Ryaby B.A. (Age 63)
Chemistry, Ph.D., Chief Scientific Officer
Mr. Dan E. Yarbrough
VP of Investor Relations
Ms. Jill Mason
Chief Ethics & Compliance Officer
Ms. Suzanne Armstrong
VP of HR
Mr. Ehab M. Esmail (Age 50)
Sr. VP of Quality, Regulatory & Clinical Affairs

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

OFIX Stock - Frequently Asked Questions

Should I buy or sell Orthofix Medical stock right now?: 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Orthofix Medical in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" OFIX shares.
View OFIX analyst ratings or view top-rated stocks.
What is Orthofix Medical's stock price forecast for 2022?: 1 Wall Street analysts have issued 12 month target prices for Orthofix Medical's stock. Their OFIX share price forecasts range from $45.00 to $45.00. On average, they anticipate the company's share price to reach $45.00 in the next year. This suggests a possible upside of 95.4% from the stock's current price.
View analysts price targets for OFIX or view top-rated stocks among Wall Street analysts.
How have OFIX shares performed in 2022?: Orthofix Medical's stock was trading at $31.09 at the beginning of the year. Since then, OFIX shares have decreased by 25.9% and is now trading at $23.03.
View the best growth stocks for 2022 here.
When is Orthofix Medical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Friday, November 4th 2022.
View our OFIX earnings forecast.
How were Orthofix Medical's earnings last quarter?: Orthofix Medical Inc. (NASDAQ:OFIX) released its earnings results on Friday, November, 5th. The medical device company reported $0.10 earnings per share for the quarter, missing the consensus estimate of $0.13 by $0.03. The medical device company earned $112.43 million during the quarter, compared to the consensus estimate of $112.90 million. Orthofix Medical had a positive trailing twelve-month return on equity of 1.90% and a negative net margin of 8.00%. During the same quarter last year, the business posted $0.31 earnings per share.
What guidance has Orthofix Medical issued on next quarter's earnings?: Orthofix Medical issued an update on its FY 2022 earnings guidance on Friday, August, 12th. The company provided EPS guidance of $0.45-$0.55 for the period. The company issued revenue guidance of $455.00 million-$465.00 million, compared to the consensus revenue estimate of $479.18 million.
What is Brad Mason's approval rating as Orthofix Medical's CEO?: 32 employees have rated Orthofix Medical Chief Executive Officer Brad Mason on Glassdoor.com. Brad Mason has an approval rating of 73% among the company's employees.

What other stocks do shareholders of Orthofix Medical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Orthofix Medical investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Edwards Lifesciences (EW), Gilead Sciences (GILD), Biogen (BIIB), Pfizer (PFE), Exxon Mobil (XOM), Advanced Micro Devices (AMD), bluebird bio (BLUE) and Esperion Therapeutics (ESPR).
What is Orthofix Medical's stock symbol?: Orthofix Medical trades on the NASDAQ under the ticker symbol "OFIX."
Who are Orthofix Medical's major shareholders?: Orthofix Medical's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Paradice Investment Management LLC (4.80%), Victory Capital Management Inc. (1.26%), JPMorgan Chase & Co. (0.86%), Royce & Associates LP (0.80%), Paradigm Capital Management Inc. NY (0.75%) and Principal Financial Group Inc. (0.67%). Insiders that own company stock include Brad Mason, Catherine M Burzik, James F Hinrichs, Jon Carl Serbousek, Kimberley A Elting, Michael E Paolucci, Rice Doug and Ronald A Matricaria.
View institutional ownership trends.
How do I buy shares of Orthofix Medical?: Shares of OFIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Orthofix Medical's stock price today?: One share of OFIX stock can currently be purchased for approximately $23.03.
How much money does Orthofix Medical make?: Orthofix Medical (NASDAQ:OFIX) has a market capitalization of $458.57 million and generates $464.48 million in revenue each year. The medical device company earns $-38,380,000.00 in net income (profit) each year or ($1.86) on an earnings per share basis.
How many employees does Orthofix Medical have?: The company employs 1,087 workers across the globe.
When was Orthofix Medical founded?: Orthofix Medical was founded in 1980.
How can I contact Orthofix Medical?: Orthofix Medical's mailing address is 3451 Plano Parkway, Lewisville TX, 75056. The official website for the company is www.orthofix.com. The medical device company can be reached via phone at (214) 937-2000, via email at markquick@orthofix.com, or via fax at 599 9 461 6978.

This page (NASDAQ:OFIX) was last updated on 8/12/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Orthofix Medical - OFIX Stock Forecast, Price & News

Orthofix Medical MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Orthofix Medical (NASDAQ:OFIX) Stock

Wall Street Analyst Weigh In

Orthofix Medical Price Performance

OFIX Stock News Headlines

OFIX Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Insiders & Institutions

OFIX Stock - Frequently Asked Questions

Should I buy or sell Orthofix Medical stock right now?

What is Orthofix Medical's stock price forecast for 2022?

How have OFIX shares performed in 2022?

When is Orthofix Medical's next earnings date?

How were Orthofix Medical's earnings last quarter?

What guidance has Orthofix Medical issued on next quarter's earnings?

What is Brad Mason's approval rating as Orthofix Medical's CEO?

What other stocks do shareholders of Orthofix Medical own?

What is Orthofix Medical's stock symbol?

Who are Orthofix Medical's major shareholders?

How do I buy shares of Orthofix Medical?

What is Orthofix Medical's stock price today?

How much money does Orthofix Medical make?

How many employees does Orthofix Medical have?

When was Orthofix Medical founded?

How can I contact Orthofix Medical?

MarketBeat Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources

Overall MarketRank^™